Jagdeep Dhankhar resigns as Vice President of India citing health reasons
Jagdeep Dhankhar has resigned from the post of Vice President of India with immediate effect, citing health reasons and the need to follow medical advice. His resignation letter, addressed to the Hon'ble President of India, was submitted on Monday in accordance with Article 67(a) of the Constitution.
In his letter, Dhankhar expressed deep gratitude to the President of India for her unwavering support and for maintaining a wonderful working relationship during his tenure. He also extended thanks to the Prime Minister and the Council of Ministers for their cooperation and support, calling his time in office an invaluable learning experience.
Dhankhar reflected on his tenure with pride, describing it as a privilege to witness and contribute to India's economic progress and global rise. He stated, 'As I leave this esteemed office, I am filled with pride in Bharat's global rise and phenomenal achievements and hold unwavering confidence in her brilliant future.'
Concluding his letter, he thanked the Members of Parliament and the people of India for their warmth, trust, and affection, which he said would remain cherished in his memory.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
As latest meme-stock drama unfolds, there's one thing that is different this time around
Meme-stock mania might be back, but old heads may have noticed that the moves this time around are lacking a certain explosiveness. To be sure, stocks like Opendoor Technologies Inc. OPEN, Kohl's Corp. KSS, GoPro Inc. GPRO and Krispy Kreme Inc. DNUT have still tallied huge moves. But the action has lacked a certain squeeze-y quality that was evident when GameStop Corp. GME took off in January 2021. During that month, shares of the struggling videogame retailer climbed more than 2,400% at their peak. America's 63 million family caregivers are mostly unpaid, stressed and begging for help Wall Street braces for deluge of Treasury bills, a crucial test of market demand My ex-husband's benefit will be $2,600 at retirement age, and mine is $2,200. Can I claim on his record instead? Homeowners in these states are the winners if Trump ends capital-gains taxes for home sellers As it turns out, there might be a fairly straightforward explanation for this. Garrett DeSimone, head of quantitative research at OptionMetrics, pointed out in commentary shared with MarketWatch on Thursday that the cost to borrow shares of Kohl's and Rocket Cos. Inc. RKT, another participant in the latest meme-stock drama, hasn't risen nearly as much as what investors witnessed with GameStop during its initial meme-inspired run. 'Market makers appear well positioned to provide liquidity in the latest rallies of Kohl's and Rocket, as reflected by implied lending rates. After the initial hype, borrowing costs have snapped back to moderate levels around 10% annualized,' DeSimone wrote in emailed commentary shared with MarketWatch. 'This stands in stark contrast to GameStop's January 2021 run, when lending costs soared to nearly 80% annualized, making the stock virtually impossible to borrow,' he added. What does that mean, exactly? 'Overall, this suggests that the potential for an extreme short squeeze is likely limited,' DeSimone said. The implied lending rate reflects the cost of shorting, derived from options prices and expressed on an annualized basis. For example, a 10% implied lending rate means that it would cost 10% of the stock's value a year to maintain a short position, DeSimone noted. Implied lending rates can also indicate the potential strength of a short squeeze, as high borrowing costs make it prohibitively expensive for an investor who has sold a stock short to maintain the position. One reason this has changed between 2021 and now, according to DeSimone, is that market makers have adjusted their pricing, removing some of the barriers to short selling that investors experienced last time around. However, this hasn't done much to dissuade investors — particularly those congregating on platforms like Reddit's RDDT WallStreetBets — from betting on stocks that have high short interest. As Bespoke Investment Group pointed out in a report shared with MarketWatch on Thursday, heavily shorted shares have dramatically outperformed the broader market since the S&P 500 SPX hit its 52-week closing low on April 8. 'His income is limited': Should I pay $800 a month towards my husband's $67,000 student debt? As latest meme-stock drama unfolds, there's one thing that is different this time around 'If I was writing the checks at Coke, I wouldn't write the check for this,' one expert says about cane-sugar Coke
Yahoo
5 hours ago
- Yahoo
Top Research Reports for NVIDIA, Netflix & Goldman Sachs
Friday, July 25, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Netflix, Inc. (NFLX), and The Goldman Sachs Group, Inc. (GS), as well as a micro-cap stock, AMREP Corp. (AXR). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. You can see all of today's research reports here >>> Ahead of Wall Street The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning. You can read today's AWS here >>> Pre-Markets Moderate in the Green for Another Up-Week NVIDIA's shares have outperformed the Zacks Semiconductor - General industry over the past year (+54.7% vs. +45.3%). NVIDIA is benefiting from the strong growth of artificial intelligence (AI) and high-performance, accelerated computing. The growing demand for generative AI and large language models using graphics processing units (GPUs) based on NVIDIA's Hopper and Blackwell architectures is aiding data center revenues. However, a limited supply of Blackwell GPUs could hinder its ability to meet demand. Rising costs associated with the production of more complex AI systems will hurt margins. (You can read the full research report on NVIDIA here >>>) Shares of Netflix have outperformed the Zacks Broadcast Radio and Television industry over the past year (+87.0% vs. +66.6%). Netflix delivered strong second-quarter results with earnings of $7.19 per share (beating estimates by 1.7%) and revenue of $11.07 billion (up 16% YoY). The quarter was highlighted by Squid Game S3 becoming the company's sixth biggest season ever with 122M views. Operating income surged 45% to $3.8 billion with margins expanding to 34% from 27% last year, driven by price increases and low churn rates. Netflix raised its full-year 2025 revenue guidance to $44.8-$45.2 billion and increased operating margin targets to 29.5%. (You can read the full research report on Netflix here >>>) Goldman Sachs' shares have outperformed the Zacks Financial - Investment Bank industry over the past year (+44.1% vs. +39.8%). The company's second-quarter 2025 results benefited from solid growth in the Global Banking & Markets division. Its refocus on the core strengths of investment banking (IB) and trading businesses through restructuring, along with acquisitions and expansion in private equity credit, is expected to boost global presence and diversify revenues. However, given the current geopolitical concerns, Goldman's high dependence on overseas revenues is worrisome. Also, the company's rising expenses due to ongoing investments in technology are concerning. (You can read the full research report on Goldman Sachs here >>>) Shares of AMREP have outperformed the Zacks Real Estate - Development industry over the past year (+2.7% vs. -14.1%). AMREP's net income surged 246.5% to $8.8 million for the nine months ended Jan. 31, 2025, with earnings per diluted share rising from $0.48 to $1.64. Home sales revenue grew 93.3% to $18.4 million, supported by strong demand in New Mexico, with 101 homes in production. However, elevated mortgage rates and affordability concerns may pressure future growth. AMREP faces risks from land sale concentration, project delays, and declining investment asset sales, impacting growth sustainability. (You can read the full research report on AMREP here >>>) Other noteworthy reports we are featuring today include AstraZeneca PLC (AZN), Gilead Sciences, Inc. (GILD), and Snap Inc. (SNAP). Mark VickerySenior Editor Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>> Today's Must Read NVIDIA (NVDA) Rides on Strong Adoption of GPUs, Partnerships Netflix (NFLX) Rides on Subscriber Growth, Original Content Strength in IB Business Aids Goldman (GS) Amid Cost Woes Featured Reports Key Drugs Aid AstraZeneca (AZN) Sales, Pipeline StrongAstraZeneca's key drugs like Lynparza, Tagrisso, Imfinzi and Farxiga should continue to drive sales. Per the Zacks analyst, its pipeline is strong, with pivotal data readouts lined up. HIV Franchise Fuel Gilead (GILD) Amid Oncology ChallengesPer the Zacks analyst, Gilead's strong momentum in HIV franchise and Liver disease franchise drive growth for the company. However, the Cell therapy franchise is facing challenges. Strategic Investments, Acquisitions Aid California Water (CWT)Per the Zacks analyst, California Water's infrastructure investments should help it provide reliable services. It gains from the expansion of operations through acquisitions and organic activities. Kirby (KEX) Benefits From Share Buyback Amid Rising ExpensesPer the Zacks analyst, rewarding shareholders through share buybacks boosts investor confidence and positively impacts Kirby's bottom line. Rising expenses continue to act as a concern. Subscriber Strength Aids America Movil (AMX) Amid Tariff WoesPer the Zacks analyst, increasing user count and widespread revenue growth across all business units and regions are driving America Movil's performance. U.S.-imposed tariff uncertainty concerns. Casey's (CASY) Grocery & General Merchandise Unit to Fuel Sales Per the Zacks analyst, expanded assortment of Grocery & General Merchandise category are likely to fuel Casey's sales. The segment recorded same-store sales growth of 1.8% in the fourth-quarter. Walgreens (WBA) Gains on U.S. Retail Growth, New LaunchesThe Zacks analyst is upbeat on Walgreens' U.S Retail Pharmacy's turnaround, driven by new strategic merchandising initiatives and omni-channel expansion. Recent product launches also seem strategic. New Upgrades EchoPark Segment Strength Aids Sonic Automotive (SAH)EchoPark posted record Q2 income, emerging as Sonic's key growth driver. The Zacks analyst sees its data-driven inventory strategy and refined business model powering continued momentum ahead. Tenet (THC) to Gain From USPI Strength & Strategic DivestmentsPer the Zacks analyst, the rising surgical cases in the USPI business will drive Tenet Healthcare's performance, while divestments will help allocate capital to higher-return investments. Solid User Growth & Premium Content Demand Aids Snap (SNAP)Per the Zacks analyst, Snap benefits from an improving user growth driven by strong adoption of Augmented Reality (AR) Lenses and demand for premium content including Shows. New Downgrades Core Lab's (CLB) Revenue Hurt by Ongoing Sanction & TariffsThe Zacks analyst believes that despite partial recovery in assay services in Q2, uncertainty still looms over Core's revenue due to ongoing geopolitical conflicts and sanctions & tariffs. Weyerhaeuser (WY) is Hurting From Macro Risks & High CostsPer the Zacks analyst, Weyerhaeuser's prospects are hurting from the ongoing global market uncertainties and elevated cost and expense structure. A pause on China export concerns its sales volume. High Costs & Macro Woes Ail BJ's Restaurants (BJRI) ProspectsPer the Zacks analyst, BJ's Restaurants operations are likely to be affected by food inflation and potential tariff-related margin pressures. Also, an uncertain macro environment pose concerns. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Goldman Sachs Group, Inc. (GS) : Free Stock Analysis Report AstraZeneca PLC (AZN) : Free Stock Analysis Report Netflix, Inc. (NFLX) : Free Stock Analysis Report Gilead Sciences, Inc. (GILD) : Free Stock Analysis Report NVIDIA Corporation (NVDA) : Free Stock Analysis Report Snap Inc. (SNAP) : Free Stock Analysis Report AMREP Corporation (AXR): Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
5 hours ago
- Yahoo
Microchip Tech (MCHP) Sheds 6.7% as Chip Giant Signals Soft Outlook
We recently published . Microchip Technology Incorporated (NASDAQ:MCHP) is one of the worst performers on Wednesday. Microchip Technology declined by 6.66 percent on Wednesday to close at $70.25 apiece after a semiconductor giant signaled weaker demand and a cautious outlook for the industry. Microchip Technology Incorporated (NASDAQ:MCHP) dropped alongside its semiconductor peers, including STMicroelectronics N.V. (NYSE:STM), and NXP Semiconductors N.V. (NASDAQ:NXPI), among others, following giant player Texas Instruments' weaker-than-expected outlook for the remainder of the year. Analysts noted a tone shift from Texas Instruments' executives in relation to the recovery of the semiconductor industry, compared with previous quarters. Despite being a US-based company, Microchip Technology Incorporated (NASDAQ:MCHP) stands to bear the indirect impact of President Donald Trump's imposition of tariffs on various global industries, which it supplies. Microchip Technology Incorporated's (NASDAQ:MCHP) solutions serve more than 123,000 customers across industrial, automotive, consumer, aerospace, defense, communications, and computing markets. While we acknowledge the potential of MCHP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
